Key Highlights
- Rentokil Initial plc (LSE: RTO) has spent 2026 rebuilding its Leadership from the top down, and the market has yet to decide whether to believe the new story.
- The FTSE 100 pest-control group installed a new chief executive in March, a new chair on 1 September, and in August split itself into two operating divisions under new regional bosses.
- On 13 August 2026, Rentokil Initial formalised its structure into two operating divisions, North America and International, a move chief executive Mike Duffy framed as creating clearer accountability and faster adoption of best practice.
- Rafael Carrasco, an external hire from Waste Management's WM Healthcare Solutions with experience running more than 200 route-based branches, joined as chief executive of North America on 3 August.
Rentokil Initial plc (LSE: RTO) has spent 2026 rebuilding its leadership from the top down, and the market has yet to decide whether to believe the new story. The FTSE 100 pest-control group installed a new chief executive in March, a new chair on 1 September, and in August split itself into two operating divisions under new regional bosses. Yet the shares, at 353.8p on 1 September according to lse.co.uk, sit roughly 30% below their April high of 506.8p, after the half-year report on 30 July 2026 retired the long-promised North American Margin target. Is a world leader in a resilient, route-based service industry being marked down for a temporary reset, or has the Terminix integration inflicted lasting damage? The next test is the third-quarter trading update on 22 October.
Two divisions, three new leaders: the August reorganisation
On 13 August 2026, Rentokil Initial formalised its structure into two operating divisions, North America and International, a move chief executive Mike Duffy framed as creating clearer accountability and faster adoption of best practice. International brings together Europe, the UK, Ireland and Sub-Saharan Africa, Asia and MENAT, Latin America and the Pacific. Three appointments accompanied the change. Rafael Carrasco, an external hire from Waste Management's WM Healthcare Solutions with experience running more than 200 route-based branches, joined as chief executive of North America on 3 August. Phill Wood, who has led the UK, Ireland and Sub-Saharan Africa since 2009, became chief executive of International. Matt Jochim, a 20-year McKinsey operator, joins as group chief transformation officer on 7 September. "Our focus is now firmly on execution and delivering the improved performance we know this Business is capable of," Duffy said. The reorganisation completed a wider changing of the guard: Duffy succeeded Andy Ransom on 16 March, and Thérèse Esperdy, the Imperial Brands chair, replaced Richard Solomons as chair on 1 September.
What Rentokil Initial does
Rentokil Initial is one of the world's largest pest-control providers, alongside a hygiene and wellbeing business supplying washroom and specialist hygiene services. It reports in US dollars, a legacy of its 2022 Terminix acquisition, which made North America its biggest market: in the first half of 2026 the region generated $2,197m of group Revenue of $3,589m, with International contributing $1,392m. The model is route-based and recurring: technicians service residential and commercial customers from local branches, supported by around 660,000 PestConnect connected devices across some 40,000 sites. North America is being reshaped around roughly 30 retained brands, a growing satellite-branch network and a new head office in Dallas, Texas. The group completed the €339m sale of its France Workwear business on 30 September 2025.
Half-year results: steady numbers, a retired target
For the six months to 30 June 2026, revenue was $3,589m, up 6.7% reported with organic growth of 3.6%. Adjusted operating profit rose 6.6% at constant currency to $556m, lifting the adjusted margin 0.3 percentage points to 15.5%. Reported profit before tax climbed 21.8% to $263m; adjusted profit before tax was $459m, up 9.8%. Adjusted Basic Earnings Per Share rose 8.3% to 13.50 cents and the Interim Dividend was raised 8.0% to 4.48 cents, or 3.29p, payable on 21 September. Cash generation was a highlight. Free Cash Flow increased 12.8% to $318m at 96% conversion, and net Debt eased to $3,575m from $3,650m at the 2025 year-end, taking Leverage to 2.4 times EBITDA, inside the 2 to 2.5 times target range for the first time since the Terminix deal. Liquidity headroom stands at $2.5bn. North America grew organically by 3.7%, with the adjusted margin up a full percentage point to 17.9%, helped by $45m of gross cost savings. But Duffy was blunt: "We are not yet delivering on our growth potential, leaving significant opportunities to improve." Residential lead flow weakened in the second quarter and commercial growth slowed among national accounts. The company withdrew its target of a 20% North American margin by 2027, prioritising Volume growth over short-term margin expansion, while maintaining that full-year 2026 profit should be in line with market expectations. For context, 2025 revenue was $6,908m with adjusted operating profit of $1,070m and free cash flow of $615m.
What could drive the shares next
The 22 October third-quarter trading update is the first read on whether second-quarter residential softness has stabilised and whether new North American leadership is lifting lead generation. Investors will also want evidence that the reorganisation improves customer retention, which in North America stood at 80.7% at the half-year against 86.1% in International. Cost savings offer a second lever: the North American programme reached an annualised gross run rate of around $90m in the first half, and International has begun its own simplification programme. Bolt-on M&A continues, with 14 businesses bought for $37m in the first half and roughly $120m planned for the year, down from the $200m guided in March. Leverage inside the target range also gives the board more balance-sheet flexibility than at any point since 2022.
Risks investors should watch
The most immediate risk is that North American Demand stays sluggish. Pest Control Services grew only 2.6% organically in the first half, and the company itself flagged weaker residential lead flow. The pivot to volume over margin means profitability could stall if growth does not follow, and retiring the 2027 margin target removes a benchmark investors had relied upon. Termite litigation is a live exposure. The provision was raised by $201m to $384m at the end of 2025 on higher claims and settlement costs, and the company guides to cash utilisation of $115m to $125m in 2026. Transformation costs of around $70m in North America, plus $35m to $45m of other one-off items, will weigh on reported earnings, while net debt of $3.6bn carries adjusted interest guided at $210m to $220m. Sterling investors carry dollar exposure on earnings and dividends, and an entirely new leadership line-up brings execution risk. Broker sentiment is mixed: Investing.com reported a downgrade to Neutral by BNP Paribas Exane on 31 July, alongside retained positive ratings from UBS and JPMorgan.
Outlook
Rentokil Initial enters the autumn with an entirely new leadership line-up and a share price close to its 52-week low of 329.7p set on 3 August. The half-year numbers were respectable, cash generation strong and leverage back within target, but the market is waiting for proof that North America can grow rather than simply cut costs. The 22 October trading update, the early months of the two-division structure and the pace of termite cash outflows are the items to monitor. Whether 2026 is remembered as the year the story was overlooked, or the year the reset began, will depend less on organisational charts than on residential lead flow in the United States.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...